Effect of preseasonal enzyme potentiated desensitisation (EPD) on plasma. IL-6 and IL-10 of grass pollen-sensitive asthmatic children

Allergie et Immunologie

Volumn 29, Issue 5, 1997, Pages 120-125

  Ippoliti, F ^a   Ragno, V ^a   Del Nero, A ^b   McEwen, L M ^b   McEwen, H ^b,c   Businco, L ^a  

^a Dept of Exp Medicine and Pathology ^*  (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

asthma; EPD; IL 10; IL 6

Indexed keywords

ALLERGEN; BETA GLUCURONIDASE; BIOLOGICAL RESPONSE MODIFIER; INTERLEUKIN 10; INTERLEUKIN 6;

ALLERGY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; PLASMA;

ASTHMA; CHILD; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; GLUCURONIDASE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; POACEAE; POLLEN;

EID: 0030969151     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. McEWEN L.M., STARR M.S. - Enzyme potentiated hyposensitisation 1. The effect of pre-treatment with b-glucuronidase, hyaluronidase and antigen on anaphylactic sensitivity of guinea pigs, rats and mice. Int. Arch Allergy 1972 : 152-158.
2. McEWEN L.M. - Enzyme of sugars and diols on enzyme potentiated hyposensitisation. J Physiol 1972, 230 : 65-66P.
3. McEWEN L.M. - Enzyme potentiated hyposensitisation II. Effects of glucosem glucosamine, N-Acetylamino-sugars and gelatin on the ability of b-glucuronidase to block the anamnestic response to antigen in mice. Ann Allergy 1973, 31 : 79-83.
4. McEWEN L.M., NICHOLSON M., KITCHEN I., WHITE S. - Enzyme potentiated hyposensitisation III, Control by sugars and diols of the immunological effect of b-glucuronidase in mice and patients with hay fever. Ann Allergy 1973, 31: 543-550.
5. McEWEN L.M., NICHOLSON M., KITCHEN T., O'GERMAN I., WHITE S. - Enzyme potentiated hyposensitisation IV, Effect of protamine on the immunogical behaviour of b-glucuronidase in mice and patients with hay fever. Ann Allergy 1975, 34 : 290-295.
6. FELL P., BROSTOFF J. - A single-dose desensitisation for summer hay fever. Results of a double-blind study 1988. Eur. J. Clin Pharmacol 1990, 38 : 77-79.
7. LONGO G., POLI F., BERTOLI G. - Efficacia clinica di un nuovo trattamento iposensibilizzante, EPD (Enzime potentiated desensitisation) nella terapia della pollinosi. Riforma Med 1992, 107 : 171-176.
8. ANGELINI G., CURATOLI G., D'ARGENTO V., VENA G.A. Pollinosi : Una nuova metodica di immunoterapia. The Med. J. of Surg. and Med. ISSN 1122-1771 Vo. 1, No 4 December 1993-pp. 237-292.
9. ASTARITA C., SCALA G., SPROVIERO S., FRANCESE A. - A double-blind placebo controlled trial of enzyme potentiated desensitisation in the treatment of pollinosis. J. Invest Allergol Clin Immunol, July-August 1996 ; Vol. 6 (4).
10. CANTANI A., RAGNO V., MONTELEONE M.A., LUCENTI P., BUSINCO L. - Enzyme potentiated desensitisation in children with asthma and mite allergy : A double-blind study. J. Invest Allergol Clin Immunol, July-August 1996 ; Vol. 6 (4) : 270-276.
11. EGGER J., STOLLA A., McEWEN L.M. - Controlled trial of hyposensitisation in 2 children with food-induced hyperkinetic syndrome. Lancet 1992, 339 : 1150-1153.
12. ROMAGNANI S. - Regulation and deregulation of human IgE synthesis. Immunol Today 1990, 11 : 316-321.
13. DEROCQ J.M. - Interleukin-13 stimulates interleukin-6 production by human keratinocytes : Similarity with interleukin-4. FEBS Letter 1994, 343 : 32-36.
14. ULLRICHE S.E. - Mechanism involved in the systemic suppression of antigen presenting cell function by UV irradiation : Keratinocyte-derived interleukin-10 modulates antigen-presenting cell function of splenic adherent cell. J Immunol 1994, 152 : 3410-3416.
15. DELEURAN B., IVERSEN L., KRISTENSEN M., FIELD M., KRAGBALLE K., THESTRUP-PEDERSEN K., STENGAARD-PEDERSEN K. - Interkeukin-8 and 15-lipoxygenase activity in rheumatoid arthritis : In vitro anti-inflammatory effects by interleukin-4 and interleukin-10, but not by interleukin-1 receptor antagonist protein. Brit K Rheumatol 1994, 33 : 520-525.
16. NIIRO H. et al. - Interleukin-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes. Int Immunol 1994, 6 : 661-664.
17. FERGUSON T.A., DUBE P., GRIFFITH T.S. - Regulation of contact hypersensitivity by interleukin-10. J Exp Med 1994, 179 : 1597-1604.
18. KATSIKIS P.D;, CHU C.Q., BRENNAN F.M., MAININ R.N., FELDMANN M. - Innumoregulatory role of interleukin-10 in rheumatoid arthritis. J Exp Med 1994, 179 : 1517-1527.
19. ENK A.H., SALOGA J., BECKER D. - B1P6 madzadeh M. KNOP J. - Introduction of hapten-specific tolerance by interleukin-10 in vivo. J Exp Med 1994, 179 : 1397-1402.
20. PEGUET-NAVARRO J., MOULON C., CAUX C., DALBIEZ-GAUTHIER C., BAN,CHEREAU J., SCHMITT D. - Interleukin-10 inhibits the primary allogeneic T-cell response to human epidermal Langerhans cells. Eur J Immunol 1994, 24 : 884-891.
21. WILLEMS F., MARCHANT A., DELVILLE J.P., GERARD C., DELVAUX A., VELU T., DE BOER M., GOLDMAN M. - Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994, 24 : 1007-1009.
22. GIMMI C.D., FREEMAN G.J., GRIBBE, J.G., GRAY G., NADLER L.M. - Human T-cell clonal anergy is induced antigen presentation in the absence of B7 costimulation. Proc Nat Acad Sci 1993, 90 : 6586-6590.